drugset / Trial / NCT00170456
Phase II Study of Range and Schedule of rPA Doses
Phase 2
Completed
415 enrolled
PharmAthene UK Limited
National Institute of Allergy and Infectious Diseases (NIAID) · collab
RandomizedParallel-groupSingle-blindPrevention
Summary
This is a dose ranging study comparing different vaccine schedules of rPA vaccine for anthrax. Safety and the capability to induce an immune response will be evaluated.
Timeline
- Start
- 2005-03
- Primary completion
- 2007-01
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | rPA vaccine | Vaccine | — | — |